IFITM5 Antibody
-
中文名稱:IFITM5兔多克隆抗體
-
貨號:CSB-PA011028HA01HU
-
規(guī)格:¥440
-
圖片:
-
其他:
產(chǎn)品詳情
-
產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) IFITM5 Polyclonal antibody
-
Uniprot No.:
-
基因名:IFITM5
-
別名:IFITM5; Interferon-induced transmembrane protein 5; Bone-restricted interferon-induced transmembrane protein-like protein; BRIL; Dispanin subfamily A member 1; DSPA1
-
宿主:Rabbit
-
反應種屬:Human
-
免疫原:Recombinant Human Interferon-induced transmembrane protein 5 protein (1-36AA)
-
免疫原種屬:Homo sapiens (Human)
-
標記方式:Non-conjugated
本頁面中的產(chǎn)品,IFITM5 Antibody (CSB-PA011028HA01HU),的標記方式是Non-conjugated。對于IFITM5 Antibody,我們還提供其他標記。見下表:
-
克隆類型:Polyclonal
-
抗體亞型:IgG
-
純化方式:>95%, Protein G purified
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式:Liquid
-
應用范圍:ELISA, IHC, IF
-
推薦稀釋比:
Application Recommended Dilution IHC 1:20-1:200 IF 1:50-1:200 -
Protocols:
-
儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產(chǎn)品
靶點詳情
-
功能:Required for normal bone mineralization.
-
基因功能參考文獻:
- Two mutations in IFITM5 causing distinct forms of osteogenesis imperfect. PMID: 24478195
- The point mutation, c.-14C>T in the 5'-untranslated region of IFITM5, is responsible for osteogenesis imperfecta type V in Chinese patients. PMID: 23977282
- The IFITM5 5' UTR was sequenced in 9 heterozygous subjects with osteogenesis imperfecta type V. Both wild-type and mutant IFITM5 mRNA transcripts were present in bone. Identical mutations have variable phenotypic expression, even within the same family. PMID: 24674092
- The bone mineral density varied greatly, even within families. Our study thus highlights the phenotypic variability of OI type V caused by the IFITM5 mutation. PMID: 23408678
- Recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. PMID: 23813632
- IFITM5 mutation is associated with Osteogenesis imperfecta type V. PMID: 23804581
- study demonstrates the presence of a recurrent IFITM5 mutation in a population of patients with osteogenesis imperfecta type V; even though the disease-causing mutation is identical among patients, the interindividual phenotypic variability is considerable PMID: 23240094
- A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V. PMID: 22863190
- A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. PMID: 22863195
顯示更多
收起更多
-
相關疾病:Osteogenesis imperfecta 5 (OI5)
-
亞細胞定位:Cell membrane; Multi-pass membrane protein.
-
蛋白家族:CD225/Dispanin family
-
組織特異性:Detected in bone. Detected in osteoblasts and fibroblasts (at protein level). Detected in bone. Detected in osteoblasts and fibroblasts.
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-